A once-a-day jab that scientists have created will now effectively fight obesity.
Liraglutide not only controls the symptoms of diabetes but also leads to significant weight loss.
Earlier this year, the super drug was given the go-ahead by European regulators. And now, latest tests have shown it to be significantly more effective than fat pills.
In study trials, the jab has shown promise in helping people lose weight by increasing the "full" feeling after eating and by slowing the speed at which their stomach empties, reports The Daily Express.
What's more, it lowers blood pressure, a major factor in the development of heart disease.
In the study by Professor Arne Astrup, of the University of Copenhagen, published in The Lancet, high doses of liraglutide were found to lead to greater weight loss than the prescription-only drug orlistat.
The authors said: "The results indicate the potential benefit of liraglutide, in conjunction with an energy-deficit diet, in the treatment of obesity."
Obesity expert Professor Steve Bloom, of Imperial College London, said: "At last science is providing treatments that work in obesity. As we all are dying earlier from our excessive fat, this is a breakthrough."